MBOAT2 and pancreatic adenocarcinoma: Furthermore, the GEPIA database demonstrated that MBOAT2 overexpression was connected to a worse prognosis in pancreatic adenocarcinoma, mesothelioma, uveal melanoma, urothelial carcinoma, and adrenocortical carcinoma but was associated with longer survival in kidney renal clear cell carcinoma (Figure 4).